Table 4.

Disease-modifying antirheumatic drug and prednisone use in the early synovitis patients at initial visit and year-1 follow up

Patient group	DMARD at initial visit	DMARD at year 1 follow-up	Prednisone at initial visit	Prednisone at year 1 follow-up
RF+ RA	28/69 (41%)	46/67 (86%)	25/69 (36%)	25/67 (37%)
RF- RA	14/36 (39%)	27/34 (79%)	16/36 (44%)	17/36 (50%)
SpA	8/43 (19%)	10/37 (29%)	11/43 (26%)	3/37 (8%)
UA	11/90 (12%)	18/79 (23%)	10/90 (11%)	9/79 (23%)

Values are expressed as number taking/total (%). DMARD, disease-modifying antirheumatic drug; RA, rheumatoid arthritis; RF, rheumatoid factor; SpA, spondyloarthropathy; UA, undifferentiated arthritis.